Ciaga Private Limited

A Pharma Franchise Company for Vitiligo and Eczema offers a comprehensive range of dermatology medicines formulated to manage skin depigmentation, inflammation, itching, and dryness. The product portfolio includes topical corticosteroids, calcineurin inhibitors, antifungal combinations, emollients, moisturizers, and immune-modulating therapies manufactured under WHO-GMP standards. These products are developed to ensure safety, efficacy, and patient compliance. The franchise opportunity provides monopoly rights, competitive pricing, attractive profit margins, promotional support, and timely product supply. With rising awareness of chronic skin disorders, partnering with a reliable vitiligo and eczema pharma franchise ensures sustainable growth and a strong presence in the dermatology segment.